Kuros Mulls Options After Baxter Exits Three Programs
By Cormac Sheridan
Wednesday, April 27, 2011
Kuros Biosurgery AG's longstanding relationship with Baxter International Inc. has dwindled to just one development program following a decision by the latter to hand back rights to three programs it had previously licensed: KUR-111, KUR-113 and KUR-115.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.